Spots Global Cancer Trial Database for Experience in Borderline Ovarian Tumors
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Experience in Borderline Ovarian Tumors
Official Title: Borderline Ovarian Tumors: Results of a Retrospective, Single-center Experience
Study ID: NCT05791838
Conditions
Interventions
Study Description
Brief Summary: Borderline ovarian tumors (BOTs) comprise 15-20% of primary ovarian neoplasms and represent an independent disease entity among epithelial ovarian cancers. The present study aimed to report the 8-year experience of a single center on the management and outcomes of consecutive BOTs patients. From January 2010 to December 2017, all patients with BOTs undergoing surgical treatment were included. Demographic, clinical, and pathological data were reviewed retrospectively.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Contact Details
Name: Basilio Pecorino, M.D.
Affiliation: University of Catania
Role: PRINCIPAL_INVESTIGATOR
Name: Paolo Scollo, M.D. Ph.D.
Affiliation: University of Catania
Role: STUDY_DIRECTOR
Name: Antonio Simone Laganà, M.D. Ph.D.
Affiliation: University of Palermo
Role: STUDY_CHAIR
Name: Andrea Etrusco, M.D.
Affiliation: University of Palermo
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
